Physician profile
Jason Cage
NPI 1285871913
$7,867.89
in general payments reported to CMS, 2019-2025
13 companies · $1,947 in 2025
The $1,947 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $2,404 · 2021: $1,349 · 2022: $383 · 2023: $956 · 2024: $691 · 2025: $1,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,654 · Travel and Lodging: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,653.66 |
| Travel and Lodging | $940.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,529.74 | 2020-2021 | |
| Boston Scientific Corporation | $1,469.23 | 2025 | General - Therapies, General - Pain Management |
| Impactortho, INC. | $1,200.00 | 2021 | |
| Orthofix Medical, INC. | $598.88 | 2022-2025 | Physio-Stim, Spinal-Stim, Accelstim |
| Globus Medical, INC. | $596.71 | 2024-2025 | Excelsius Deformity, Modulus, Armada |
| Medtronic, INC. | $349.73 | 2022-2023 | Cd Horizon Spinal System |
| Nuvasive, INC. | $317.85 | 2023 | |
| Bioventus LLC | $291.13 | 2021-2024 | None, Durolane |
| Stryker Corporation | $219.69 | 2023-2025 | Iconix, Salvation, Sharpshooter |
| Axogen | $137.99 | 2019 | |
| Heron Therapeutics, INC. | $110.00 | 2022 | |
| Si-Bone, INC. | $25.57 | 2024 | |
| Dilon Technologies, INC. | $21.37 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.